Jon D. Herrington

813 total citations
41 papers, 622 citations indexed

About

Jon D. Herrington is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Hematology. According to data from OpenAlex, Jon D. Herrington has authored 41 papers receiving a total of 622 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 10 papers in Hematology. Recurrent topics in Jon D. Herrington's work include Chemotherapy-related skin toxicity (6 papers), Acute Lymphoblastic Leukemia research (5 papers) and Cancer Treatment and Pharmacology (4 papers). Jon D. Herrington is often cited by papers focused on Chemotherapy-related skin toxicity (6 papers), Acute Lymphoblastic Leukemia research (5 papers) and Cancer Treatment and Pharmacology (4 papers). Jon D. Herrington collaborates with scholars based in United States and Portugal. Jon D. Herrington's co-authors include Jyoti D. Chouhan, Juhee Song, Mark W. Riggs, José A. Figueroa, Lucas Wong, Hai T. Tran, Curtis, Frank E. Mott, Robert K. Salley and Ralph V. Boccia and has published in prestigious journals such as Cancer, Supportive Care in Cancer and American Journal of Infection Control.

In The Last Decade

Jon D. Herrington

40 papers receiving 604 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jon D. Herrington United States 16 150 144 141 119 112 41 622
Dominick Latrémouille-Viau United States 15 115 0.8× 73 0.5× 69 0.5× 215 1.8× 187 1.7× 73 845
John Will United States 14 94 0.6× 92 0.6× 98 0.7× 262 2.2× 70 0.6× 29 753
Fatih Dede Türkiye 16 98 0.7× 88 0.6× 112 0.8× 52 0.4× 29 0.3× 75 663
George Wu Canada 18 226 1.5× 97 0.7× 222 1.6× 71 0.6× 46 0.4× 56 883
Patricio Rojas Chile 10 87 0.6× 111 0.8× 173 1.2× 133 1.1× 47 0.4× 29 1.0k
İmdat Dılek Türkiye 14 50 0.3× 101 0.7× 73 0.5× 214 1.8× 36 0.3× 72 553
Tom Parker United States 16 134 0.9× 19 0.1× 212 1.5× 107 0.9× 88 0.8× 27 1.1k
C. Gómez-Alamillo Spain 19 150 1.0× 85 0.6× 289 2.0× 51 0.4× 55 0.5× 55 1.1k
Collin Barker Canada 16 279 1.9× 83 0.6× 486 3.4× 137 1.2× 105 0.9× 33 1.1k
Neil McGill Australia 15 152 1.0× 102 0.7× 224 1.6× 40 0.3× 17 0.2× 35 735

Countries citing papers authored by Jon D. Herrington

Since Specialization
Citations

This map shows the geographic impact of Jon D. Herrington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon D. Herrington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon D. Herrington more than expected).

Fields of papers citing papers by Jon D. Herrington

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon D. Herrington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon D. Herrington. The network helps show where Jon D. Herrington may publish in the future.

Co-authorship network of co-authors of Jon D. Herrington

This figure shows the co-authorship network connecting the top 25 collaborators of Jon D. Herrington. A scholar is included among the top collaborators of Jon D. Herrington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon D. Herrington. Jon D. Herrington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smith, Stephanie M., et al.. (2020). Outcomes Associated With Antibiotic Cessation in Oncology Patients With Positive Respiratory Viral Panel Polymerase Chain Reaction Results. Infectious Diseases in Clinical Practice. 28(5). 277–280. 3 indexed citations
2.
Hammonds, Kendall, et al.. (2020). Characterizing the impact of magnesium and potassium-supplemented hydration with cisplatin and the subsequent electrolyte replacement requirements. Journal of Oncology Pharmacy Practice. 27(5). 1125–1131. 1 indexed citations
3.
Herrington, Jon D., et al.. (2018). Verapamil as a culprit of palbociclib toxicity. Journal of Oncology Pharmacy Practice. 25(3). 743–746. 8 indexed citations
4.
5.
Hall, James A., et al.. (2017). Dipping into the Clostridium difficile pool: Are alcohol-based dispensers fomites for C difficile?. American Journal of Infection Control. 45(11). 1279–1280. 2 indexed citations
6.
Lu, Gary, et al.. (2016). Successful Treatment of Pegaspargase-Induced Acute Hepatotoxicity with Vitamin B Complex and L-Carnitine. Baylor University Medical Center Proceedings. 29(1). 46–47. 15 indexed citations
7.
Qureshi, Sana, et al.. (2016). Concurrent gastrointestinal perforation and pulmonary embolism due to bevacizumab in an adult undergoing treatment for stage IV colon cancer. Journal of Oncology Pharmacy Practice. 23(8). 625–628. 5 indexed citations
8.
Chouhan, Jyoti D. & Jon D. Herrington. (2010). Treatment Options for Chronic Refractory Idiopathic Thrombocytopenic Purpura in Adults: Focus on Romiplostim and Eltrombopag. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 30(7). 666–683. 22 indexed citations
9.
10.
Nguyen, Sean, et al.. (2008). Lipid‐Lowering Efficacy and Safety After Switching to Atazanavir‐Ritonavir‐Based Highly Active Antiretroviral Therapy in Patients with Human Immunodeficiency Virus. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 28(3). 323–330. 23 indexed citations
11.
Brown, Erika N. & Jon D. Herrington. (2008). Review of the Relationship Between Venous Thromboembolism, Malignancy and Its Treatment. Journal of Pharmacy Practice. 21(2). 126–137. 1 indexed citations
12.
Herrington, Jon D., Hai T. Tran, & Mark W. Riggs. (2005). Prospective evaluation of carboplatin AUC dosing in patients with a BMI ≥27 or Cachexia. Cancer Chemotherapy and Pharmacology. 57(2). 241–247. 35 indexed citations
13.
Herrington, Jon D., et al.. (2005). Utilization of darbepoetin alfa and epoetin alfa for chemotherapy-induced anemia. American Journal of Health-System Pharmacy. 62(1). 54–62. 29 indexed citations
14.
Herrington, Jon D., et al.. (2002). Recurrent Peripheral Arterial Thrombosis Induced by Cisplatin and Etoposide. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 22(9). 1200–1204. 37 indexed citations
15.
Herrington, Jon D., et al.. (2002). Thalidomide for the Treatment of Relapsed and Refractory Multiple Myeloma. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 22(8). 1019–1028. 4 indexed citations
16.
Herrington, Jon D., et al.. (2002). Methotrexate‐Induced Toxic Leukoencephalopathy. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 22(9). 1183–1187. 11 indexed citations
17.
Herrington, Jon D., José A. Figueroa, Mark N. Kirstein, William C. Zamboni, & Clinton F. Stewart. (2000). Effect of hemodialysis on topotecan disposition in a patient with severe renal dysfunction. Cancer Chemotherapy and Pharmacology. 47(1). 89–93. 12 indexed citations
18.
Herrington, Jon D., et al.. (2000). Randomized, Multicenter Comparison of Oral Granisetron and Oral Ondansetron for Emetogenic Chemotherapy. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 20(11). 1318–1323. 17 indexed citations
19.
Herrington, Jon D. & José A. Figueroa. (1997). Severe Necrosis Due to Paclitaxel Extravasation. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 17(1). 163–165. 23 indexed citations
20.
Herrington, Jon D., et al.. (1997). Pharmacologic Options for the Treatment of Cachexia. Nutrition in Clinical Practice. 12(3). 101–113. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dominick Latrémouille-Viau Breakdown of academic impact, for papers by John Will Breakdown of academic impact, for papers by Fatih Dede Breakdown of academic impact, for papers by George Wu Breakdown of academic impact, for papers by Patricio Rojas Breakdown of academic impact, for papers by İmdat Dılek Breakdown of academic impact, for papers by Tom Parker Breakdown of academic impact, for papers by C. Gómez-Alamillo Breakdown of academic impact, for papers by Collin Barker Breakdown of academic impact, for papers by Neil McGill
Rankless by CCL
2026